These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3498 related items for PubMed ID: 7378986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: a Southwest Oncology Group Study.
    Costanzi JJ, Al-Sarraf M, Groppe C, Bottomley R, Fabian C, Neidhart J, Dixon D.
    Med Pediatr Oncol; 1982; 10(3):251-8. PubMed ID: 7045615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Controlled study with imidazole carboxamide (DTIC), DTIC + bacillus Calmette-Guérin (BCG), and DTIC + corynebacterium parvum in advanced malignant melanoma. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma.
    Tumori; 1984 Feb 29; 70(1):41-8. PubMed ID: 6369694
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH, Atzpodien J, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():44-9. PubMed ID: 8692119
    [Abstract] [Full Text] [Related]

  • 9. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
    Ramseur WL, Richards F, Muss HB, Rhyne L, Cooper MR, White DR, Stuart JJ, Spurr CL.
    Cancer Treat Rep; 1978 Jul 12; 62(7):1085-7. PubMed ID: 356970
    [Abstract] [Full Text] [Related]

  • 10. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.
    Green MD, MacKay IR, Buckley JC, Coates AS.
    Aust N Z J Surg; 1979 Jun 12; 49(3):335-9. PubMed ID: 289374
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of cyclophosphamide, vincristine and D.T.I.C. +/- B.C.G. in the treatment of malignant melanoma.
    Byrne MJ, Reynolds PM.
    Aust N Z J Med; 1982 Aug 12; 12(4):263-6. PubMed ID: 6958237
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
    Newlands ES, Oon CJ, Roberts JT, Elliott P, Mould RF, Topham C, Madden FJ, Newton KA, Westbury G.
    Br J Cancer; 1976 Aug 12; 34(2):174-9. PubMed ID: 962994
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemoimmunotherapy after regional lymphadenectomy for malignant melanoma.
    Abdi EA, Hanson J, McPherson TA.
    Am J Clin Oncol; 1987 Apr 12; 10(2):117-22. PubMed ID: 3565312
    [Abstract] [Full Text] [Related]

  • 14. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB, Dent PB, Blajchman M, Muirhead WM, Price RA.
    Can Med Assoc J; 1977 Jul 09; 117(1):33-6. PubMed ID: 861909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May 01; 63(9):1676-80. PubMed ID: 2467736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG.
    Karakousis CP, Emrich LJ.
    J Surg Oncol; 1987 Dec 01; 36(4):235-8. PubMed ID: 3695527
    [Abstract] [Full Text] [Related]

  • 19. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saïag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y.
    J Clin Oncol; 2004 Mar 15; 22(6):1118-25. PubMed ID: 15020614
    [Abstract] [Full Text] [Related]

  • 20. CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma.
    Konjević G, Jović V, Vuletić A, Radulović S, Jelić S, Spuzić I.
    Eur J Clin Invest; 2007 Nov 15; 37(11):887-96. PubMed ID: 17973783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 175.